Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort ascending Project # RFA # PI/Project Leader Institution Title Status
2003 R44 PAR-01-105 NEDELKOV, DOBRIN INTRINSIC BIOPROBES, INC. AFFINITY-BASED MASS SPECTROMETRY PROTEIN ASSAYS Complete
2020 R44 PAR-18-303 WINTERS, IAN PAUL D2G ONCOLOGY, INC. Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform Complete
2000 R44 PAR-99-101 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION SIMPLE, LOW-COST, ULTRA-RAPID SPECTRAL IMAGING PLATFORM Complete
2002 R44 PAR-01-105 DREES, BETH E ECHELON BIOSCIENCES, INC. PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS Complete
2000 R44 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING Complete
2002 R44 PAR-01-105 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS Complete
2000 R44 PAR-98-066 ANDERSON, N LEIGH LARGE SCALE BIOLOGY CORPORATION PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH Complete
1999 R44 PAR-98-066 LIFSHITZ, NADIA BIOPHOTONICS CORPORATION HIGH THROUGHPUT, HIGH RESOLUTION DNA SEQUENCING Complete
1999 R44 PAR-98-066 ANDERSON, N LEIGH LARGE SCALE BIOLOGY CORPORATION PROTEOMIC TECHNOLOGIES FOR CANCER RESEARCH Complete
2005 R44 RFA-CA-05-006 RUSH, JOHN CELL SIGNALING TECHNOLOGY, INC. IMMUNOAFFINITY ISOLATION OF PHOSPHOPEPTIDES Complete
2005 R44 PAR-01-105 BALGLEY, BRIAN M. CALIBRANT BIOSYSTEMS, INC. INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS Complete
2008 R44 RFA-CA-07-039 GUO, BAOCHUAN GLC BIOTECHNOLOGY, INC. MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY Complete
2006 R44 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2008 R44 RFA-CA-07-041 LEE, BRIAN W IMMUNOCHEMISTRY TECHNOLOGIES, LLC NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO Complete
2006 R44 RFA-CA-06-005 BRADY, ERIK D MICROCOSM, INC. ENHANCED CANCER MICROARRAY Complete
2008 R44 RFA-CA-07-039 LIM, MARK AMBERGEN, INC ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE Complete
2006 R44 RFA-CA-06-005 LU, PETER S. ARBOR VITA CORPORATION A NOVEL DIAGNOSTIC ASSAY FOR ONCOGENIC HUMAN PAPILLOMAVIRUSES Complete
2020 R44 PAR-18-303 FRIEDA, KIRSTEN SPATIAL GENOMICS, INC. Spatial and single cell analysis of tumor microenvironment by seqFISH+ Complete
2008 R44 RFA-CA-07-041 LEE, PHILIP J CELLASIC CORPORATION MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS Complete
2008 R44 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
1999 R43 PAR-98-066 NERI, BRUCE P THIRD WAVE TECHNOLOGIES, INC. SPECIFIC AND SENSITIVE MUTATION AND SNP DETECTION Complete
2001 R43 PAR-99-101 WANG, PENCHENG CALIBRANT BIOSYSTEMS, INC. 2-D MICROFLUIDIC GENE SCANNER Complete
2004 R43 PAR-01-105 BECKER, CHRISTOPHER H SURROMED, INC. DIFFERENTIAL EXPRESSION MEASUREMENTS OF PHOSPHOPROTEOME Complete
2016 R43 PAR-13-327 GUNDERSON, KEVIN L ENCODIA, INC. Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer Complete
2002 R43 PAR-01-105 ISRAEL, BARBARA A. PLATYPUS TECHNOLOGIES, LLC OBLIQUELY DEPOSITED SUBSTRATES FOR DETECTION OF RAS Complete
2015 R43 PAR-13-327 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. PROMOTE HPV SCREENING RATE WITH A NON-INVASIVE HPV POC CARTRIDGE Complete
1999 R43 PAR-98-066 WEAVER, DANIEL C GENOMICA CORPORATION ANALYZING GENE EXPRESSION FOR CANCER GENE DISCOVERY Complete
2001 R43 PAR-99-101 WANG, JIWU ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INNOVATIVE RNA PROFILING IN CANCER CELLS Complete
2004 R43 PAR-01-105 NIELSEN, ULRIK B. MERRIMACK PHARMACEUTICALS, INC. PRODUCTION OF ANTIBODIES SUITABLE FOR MICROARRAYS Complete
2016 R43 PAR-13-327 LIM, MARK AMBERGEN, INC Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays Complete
2002 R43 PAR-01-105 BECKER, CHRISTOPHER SURROMED, INC. AFFINITY MASS TAGS FOR DIFFERENTIAL PHENOTYPING Complete
1999 R43 PAR-98-066 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC ISOLATION AND PROFILING OF CIRCULATING PC CELLS IN BLOOD Complete
2001 R43 PAR-99-101 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS WHOLE GENOME METHYLATION ASSAY Complete
2004 R43 PAR-01-105 PARIS, MARK J VACCINEX, INC. FUNCTIONAL IDENTIFICATION OF CANCER REGULATORS Complete
2016 R43 PAR-13-327 KING, JEFFREY S VIROGENOMICS BIODEVELOPMENT, INC. Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia Complete
2000 R43 PAR-99-101 BUTT, TAUSEEF R. LIFESENSORS, INC. LIVESENSORS FOR MOLECULAR PROFILING IN PROSTATE CANCER Complete
2002 R43 PAR-01-105 STRAUME, TORE GENMETRIX, LLC ASSAY FOR DETECTION OF CANCER CHROMOSOME ABNORMALITIES Complete
1999 R43 PAR-98-066 OLINER, JONATHAN D AFFYMETRIX, INC. REVERSE-ENGINEERING SIGNAL TRANSDUCTION NETWORKS Complete
2001 R43 PAR-99-101 WILLETT, CATHERINE E PHYLONIX PHARMACEUTICALS, INC. ASSAY FOR IDENTIFYING ANGIOGENIC DRUG TARGETS Complete
2004 R43 PAR-01-105 VYKOUKAL, JODY V ADEPTAS, INC. RARE CELL ISOLATION FOR MORPHOLOGICAL & MOLECULAR STUDY Complete
2000 R43 PAR-98-066 BAMDAD, CYNTHIA C. MINERVA BIOTECHNOLOGIES CORPORATION RAPID ELECTRONIC DETECTION OF CELL SURFACE PROTEINS Complete
2002 R43 PAR-01-105 LOGE, GARY SPECTRUMEDIX CORPORATION AN AUTOMATED 2D-CAPILLARY ELECTROPHORESIS SYSTEM Complete
2000 R43 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2002 R43 PAR-01-105 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. RAPID MOLECULAR DETECTION OF PML/RARALPHA Complete
1999 R43 PAR-98-066 XANTHOPOULOS, KLEANTHIS G AURORA BIOSCIENCES CORPORATION ID OF NOVEL BREAST CANCER AGENTS BY FUNCTIONAL GENOMICS Complete
2001 R43 PAR-98-066 PERLIN, MARK W CYBERGENETICS CORPORATION AUTOMATED MULTIPLEX GENETIC ANALYSIS TECHNOLOGY Complete
2004 R43 PAR-01-105 HEILIG, JOSEPH S SOMALOGIC, INC. APTAMER DEVELOPMENT FOR CANCER DIAGNOSIS AND MANAGEMENT Complete
2003 R43 PAR-01-105 SHEN, LI SUPERARRAY BIOSCIENCE CORPORATION ID-TAG PROTEIN PROFILING ARRAY FOR THE MOLECULAR CHARACT Complete
2000 R43 PAR-98-066 BOGEN, STEVEN A CYTOLOGIX CORPORATION INSTRUMENTATION FOR IN SITU ANALYSIS TUMORS Complete
2002 R43 PAR-01-105 YANG, XING GENEOHM SCIENCES, INC. MULTIPLEXED DNA-MEDIATED ELECTOCHEMICAL SENSORS Complete

Pages